OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
OptimizeRx announced its second-quarter 2026 financial results, reporting $20.5 million in revenue and a GAAP net loss of $(0.7) million. Despite a year-over-year revenue decline, the company exceeded consensus expectations for revenue and adjusted EBITDA, which stood at $4.9 million. OptimizeRx reaffirmed its fiscal …